中国药业
中國藥業
중국약업
CHINA PHARMACEUTICALS
2015年
1期
57-58
,共2页
药学经济学%成本-效果分析%恶心呕吐%止吐
藥學經濟學%成本-效果分析%噁心嘔吐%止吐
약학경제학%성본-효과분석%악심구토%지토
pharmacoeconomics%cost-effectiveness analysis%nausea%vomiting%antiemetic
目的:评价两种方案治疗恶心呕吐的成本效果,促进临床合理、经济用药。方法回顾性分析2012年1月至2013年12月首次化疗的患者181例,分为两组,其中使用昂丹司琼静脉注射方案(A组)98例,使用托烷司琼静脉滴注(B组)83例。比较用药5 d后的疗效、不良反应和治疗成本,对两种方案进行药物经济学成本-效果分析。结果两组治疗方案的成本分别为1065.5元和861.0元;未呕吐率分别为47.96%和51.81%,未严重呕吐发生率分别为77.55%和77.11%,两组差异无统计学意义( P>0.05)。结论考虑药物的有效性、安全性,B组方案是治疗恶心呕吐的最佳治疗方案,更有经济学价值。
目的:評價兩種方案治療噁心嘔吐的成本效果,促進臨床閤理、經濟用藥。方法迴顧性分析2012年1月至2013年12月首次化療的患者181例,分為兩組,其中使用昂丹司瓊靜脈註射方案(A組)98例,使用託烷司瓊靜脈滴註(B組)83例。比較用藥5 d後的療效、不良反應和治療成本,對兩種方案進行藥物經濟學成本-效果分析。結果兩組治療方案的成本分彆為1065.5元和861.0元;未嘔吐率分彆為47.96%和51.81%,未嚴重嘔吐髮生率分彆為77.55%和77.11%,兩組差異無統計學意義( P>0.05)。結論攷慮藥物的有效性、安全性,B組方案是治療噁心嘔吐的最佳治療方案,更有經濟學價值。
목적:평개량충방안치료악심구토적성본효과,촉진림상합리、경제용약。방법회고성분석2012년1월지2013년12월수차화료적환자181례,분위량조,기중사용앙단사경정맥주사방안(A조)98례,사용탁완사경정맥적주(B조)83례。비교용약5 d후적료효、불량반응화치료성본,대량충방안진행약물경제학성본-효과분석。결과량조치료방안적성본분별위1065.5원화861.0원;미구토솔분별위47.96%화51.81%,미엄중구토발생솔분별위77.55%화77.11%,량조차이무통계학의의( P>0.05)。결론고필약물적유효성、안전성,B조방안시치료악심구토적최가치료방안,경유경제학개치。
Objective To evaluate the cost-effectiveness of two schemes for treating nausea and vomiting in order to promote rational and economic drug use in clinic. Methods The retrospective analysis of 181 cases of the first time chemotherapy in our hospital from January 2012 to December 2013 were performed. The 181 cases were divided into two groups. 98 cases used ondansetron by intravenous drip ( group A ) and 83 cases used tropisetron by intravenous drip ( group B ) . The efficacy, adverse reactions and treatment costs after 5 d were compared between the two groups. The two kinds of medication scheme were performed the cost-effectiveness analysis. Results The costs for the two medication schemes were 1 065. 5 yuan and 861. 0 yuan respectively; the non-vomiting rates were 47. 96% and 51. 81% respectively, and the occurrence rate of non-severe and non-moderate vomiting were 77. 55% and 77. 11% respectively. There was no statistically significant difference in the cure rate between the two groups. Conclusion Considering the effectiveness and safety of drugs, the scheme in the group B is the better scheme with more economic value for treating nausea and vomiting.